Earlier this year Andrew Ng made a call for a shift to data-centric AI. Quoted in an article from Forbes, Ng said “Now that the models have advanced to a certain point, we got to make the data work as well.” Since reading this article, I have cited Ng and his sentiment frequently. My conversations reminded …
In Support of Data-Centric AI for Drug Discovery Read More »
The last several months after leaving an AI/ML focused company, have been eye-opening in terms of the shift in the conversation about digital and AI transformation. The progression over my career has been steady: phase 1, scientific computing was a niche requirement to solve specific tasks phase 2, demonstrating and evangelizing on the part of …
Becoming a consultant after leaving ZebiAI at the end of March, I have had the opportunity to reach out beyond my roots at X-Chem/ZebiAI, where I headed up informatics, data science and IT over the past decade. My conclusion: It is a great time to be in DEL! Over the last decade, I have watched …
A Growing New Wave in DNA-Encoded Libraries: A Great Time to be in DEL Read More »
Working with predictive model-driven technology at my last two companies has put a fine point for me on an issue that I am certain causes ML and computational drug hunters to lose sleep. The Design-Make-Test-Analyze cycle needs a serious tune-up! Here’s the scenario for small molecule discovery at a small to medium biotech: Assume the …
The Design-Make-Test-Analyze Cycle Needs a Tune-up for AI-driven Drug Discovery Read More »
